6001 Executive Blvd, MSC 9589, Bethesda, MD 20892-9589.
National Institute on Drug Abuse, Bethesda, Maryland, USA.
J Clin Psychiatry. 2018 Oct 16;79(6):18m12174. doi: 10.4088/JCP.18m12174.
Although benzodiazepine misuse and use disorders are associated with adverse health effects, it is unknown what proportion of benzodiazepine users misuse them or meet criteria for benzodiazepine use disorders. The goal of this study was to examine the prevalence and correlates of benzodiazepine use, misuse, and use disorders among US adults.
Data from 102,000 adults 18 years and older who participated in the 2015-2016 National Surveys on Drug Use and Health were used. IMS Health Total Patient Tracker data were also examined. Descriptive analyses and multinomial logistic regressions were applied.
Among US adults in 2015-2016, 12.5% (annual average, 95% CI, 12.19%-12.81%) used benzodiazepines, 2.1% (95% CI, 2.03%-2.25%) misused benzodiazepines at least once, and 0.2% (95% CI, 0.15%-0.22%) had benzodiazepine use disorders. Among benzodiazepine users, 17.1% (95% CI, 16.30%-17.93%) misused benzodiazepines, and 1.5% (95% CI, 1.26%-1.72%) had benzodiazepine use disorders. Benzodiazepine use was associated with emergency room visits, suicidal ideation, use of most substances, and mental disorders. Benzodiazepine misuse without use disorders was associated with younger age, male sex, being black, poor educational attainment, being uninsured and unemployed, being single, having family income below $50,000, and having suicidal ideation and other specific substance use problems. Correlates of benzodiazepine use disorders were similar, but most correlates were associated with benzodiazepine use disorders more strongly than with misuse without use disorders.
While benzodiazepine use is highly prevalent among US adults, benzodiazepine use disorders are relatively rare among benzodiazepine users. Our results help characterize benzodiazepine users and identify adults at risk for misuse and use disorders.
尽管苯二氮䓬类药物的滥用和使用障碍与不良健康影响有关,但尚不清楚有多少苯二氮䓬类药物使用者会滥用此类药物或符合苯二氮䓬类药物使用障碍的标准。本研究的目的是调查美国成年人中苯二氮䓬类药物使用、滥用和使用障碍的流行率和相关因素。
本研究使用了参加 2015-2016 年全国药物使用和健康调查的 102000 名 18 岁及以上成年人的数据。还检查了 IMS Health Total Patient Tracker 数据。应用描述性分析和多项逻辑回归。
2015-2016 年,美国成年人中,12.5%(年平均,95%CI,12.19%-12.81%)使用苯二氮䓬类药物,2.1%(95%CI,2.03%-2.25%)至少一次滥用苯二氮䓬类药物,0.2%(95%CI,0.15%-0.22%)有苯二氮䓬类药物使用障碍。在苯二氮䓬类药物使用者中,17.1%(95%CI,16.30%-17.93%)滥用苯二氮䓬类药物,1.5%(95%CI,1.26%-1.72%)有苯二氮䓬类药物使用障碍。苯二氮䓬类药物的使用与急诊就诊、自杀意念、使用大多数物质和精神障碍有关。无苯二氮䓬类药物使用障碍的滥用与年龄较小、男性、黑人、教育程度较低、没有保险和失业、单身、家庭收入低于 50000 美元、有自杀意念和其他特定物质使用问题有关。苯二氮䓬类药物使用障碍的相关因素相似,但大多数相关因素与苯二氮䓬类药物使用障碍的相关性强于与无使用障碍的滥用。
虽然苯二氮䓬类药物在美成年人中使用非常普遍,但苯二氮䓬类药物使用障碍在苯二氮䓬类药物使用者中相对较少。我们的研究结果有助于描述苯二氮䓬类药物使用者,并确定有滥用和使用障碍风险的成年人。